Minted: - / 5000

1179 Seltorexant
5ee619b2df8a6cc357cd4875a324b7cf5c51851fd9db94ac2abe0cadfd623b14

Properties

Background

Red
Bottle

Gray
Cap

Gray
Syringe

Purple
Bubbles
No
Drops
No
Label
-

Chemistry

Formula
C21H22FN7O
Carbon
21
Polarity
Neutral

Seltorexant (former developmental code names MIN-202, JNJ-42847922, JNJ-922) is a selective, small-molecule antagonist of the OX₂ receptor that is under development by Minerva Neurosciences and Johnson & Johnson's Janssen Pharmaceuticals for the treatment of insomnia and major depressive disorder (MDD). As of December 2015, it is in phase II clinical trials for both insomnia and major depressive disorder.

From Wikipedia, the free encyclopedia. License: CC BY-SA.